NCT07016425 Temporal Interference for Essential Tremor
| NCT ID | NCT07016425 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Liankun_Ren |
| Condition | Essential Tremor |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2025-06-09 |
| Primary Completion | 2026-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2025-06-09 with a primary completion date of 2026-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This single-center prospective study aims to investigate the treatment efficacy of temporal interference (TI) in essential tremor patients aged 30-70.
Eligibility Criteria
Inclusion Criteria: * Aged 30-70 years old, regardless of gender. Action tremor and postural tremor in both upper limbs, or action tremor and postural tremor in one limb; * No history of mental diseases; * Informed consent signed. Exclusion Criteria: * Presence of other neurological diseases affecting the study (such as epilepsy); * Patients with moderate to severe cognitive impairment (Montreal Cognitive Assessment ≤ 18 points); * Orthopedic diseases that may affect motor symptoms; * Patients taking antipsychotic or antidepressant medications; * Presence of metal implants in the body (such as brain pacemakers or cardiac pacemakers); * History of electroconvulsive therapy; * Presence of cardiovascular risk factors, etc.
Contact & Investigator
Liankun Ren, MD
PRINCIPAL INVESTIGATOR
Xuanwu Hospital, Beijing
Frequently Asked Questions
Who can join the NCT07016425 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 70 Years, studying Essential Tremor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07016425 currently recruiting?
Yes, NCT07016425 is actively recruiting participants. Contact the research team at renlk2022@outlook.com for enrollment information.
Where is the NCT07016425 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT07016425 clinical trial?
NCT07016425 is sponsored by Liankun_Ren. The principal investigator is Liankun Ren, MD at Xuanwu Hospital, Beijing. The trial plans to enroll 10 participants.